Lymphoma Action advocates for patient involvement in the development of new lymphoma therapies. “We champion people affected by lymphoma participating and being an active voice in all aspects of ...
Tempus AI, Inc. (NASDAQ:TEM) stock is trading higher on Thursday after the company announced a collaboration with the ...
Bristol Myers Squibb's Breyanzi showed strong efficacy in Phase 2 lymphoma trial, meeting key endpoints. FDA approvals expand ...
World Cancer Day aims to raise awareness for the prevention, detection, and treatment of all kinds of cancers, with ...
Galapagos is dropping its junior CD19 CAR-T as part of the Belgian biotech’s seemingly never-ending mission to recalibrate ...
The 28-year-old missed 11 months of action after being diagnosed with Hodgkin's lymphoma in 2022. Hodgkin's lymphoma is a ...
Cyprus Mail on MSN1d
Cyprus calls for global action on childhood cancerPresident Nikos Christodoulides has called for greater international collaboration in the fight against childhood cancer on ...
With another trial win, Bristol Myers Squibb is touting Breyanzi as the CD19-directed CAR-T therapy with positive readouts in the most cancer types. | With another trial win, Bristol Myers Squibb is ...
"Only a patient can really appreciate how much ringing the bell matters. So the day he hung it up, it was the most joyous ...
The National Institutes of Health (NIH) is the largest single source of health care research funding in the U.S. The Trump ...
Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application ...
It also aims to inspire action in the fight toward a cancer-free future. KOIN 6 News and Portland’s CW are proud community partners of the Leukemia & Lymphoma Society, whose research leads to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback